CY1111280T1 - ANTI-POLLUTION FACTORS - Google Patents

ANTI-POLLUTION FACTORS

Info

Publication number
CY1111280T1
CY1111280T1 CY20111100241T CY111100241T CY1111280T1 CY 1111280 T1 CY1111280 T1 CY 1111280T1 CY 20111100241 T CY20111100241 T CY 20111100241T CY 111100241 T CY111100241 T CY 111100241T CY 1111280 T1 CY1111280 T1 CY 1111280T1
Authority
CY
Cyprus
Prior art keywords
hcv
compound
methods
provides
present
Prior art date
Application number
CY20111100241T
Other languages
Greek (el)
Inventor
John K Pratt
David A Betebenner
Pamela L Donner
Brian E Green
Dale J Kempf
Keith F Mcdaniel
Clarence J Maring
Vincent S Stoll
Rong Zhang
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/285,714 external-priority patent/US20040097492A1/en
Priority claimed from US10/625,121 external-priority patent/US20040162285A1/en
Priority claimed from US10/679,881 external-priority patent/US20050075331A1/en
Priority claimed from EP03768559A external-priority patent/EP1560827B1/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CY1111280T1 publication Critical patent/CY1111280T1/en

Links

Abstract

Η παρούσα εφεύρεση παρέχει Ένωση που αναστέλλει Πολυμεράση του HCV που έχει τον τύπο (I) και μία σύνθεση που περιλαμβάνει θεραπευτικώς αποτελεσματική ποσότητα της εν λόγω ένωσης. Η παρούσα εφεύρεση επίσης παρέχει μέθοδο αναστολής Πολυμεράσης του ιού ηπατίτιδας C (HCV), μέθοδο για αναστολή ιική αντιγραφής του HCV και μέθοδο για θεραπεία ή αποτροπή μόλυνσης HCV. Μέθοδοι για να γίνονται οι εν λόγω ενώσεις και ενδιάμεσα συνθετικά που χρησιμοποιούνται στις εν λόγω μεθόδους, παρέχονται επίσης.The present invention provides a compound that inhibits HCV Polymerase of formula (I) and a composition comprising a therapeutically effective amount of said compound. The present invention also provides a method of inhibiting hepatitis C virus polymerase (HCV), a method for inhibiting HCV viral replication, and a method for treating or preventing HCV infection. Methods for making said compounds and intermediate syntheses used in said methods are also provided.

CY20111100241T 2002-11-01 2011-03-01 ANTI-POLLUTION FACTORS CY1111280T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/285,714 US20040097492A1 (en) 2002-11-01 2002-11-01 Anti-infective agents
US10/410,853 US20040087577A1 (en) 2002-11-01 2003-04-10 Anti-infective agents
US10/625,121 US20040162285A1 (en) 2002-11-01 2003-07-23 Anti-infective agents
US10/679,881 US20050075331A1 (en) 2003-10-06 2003-10-06 Anti-infective agents
EP03768559A EP1560827B1 (en) 2002-11-01 2003-10-31 Anti-infective agents

Publications (1)

Publication Number Publication Date
CY1111280T1 true CY1111280T1 (en) 2015-10-07

Family

ID=52341418

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100241T CY1111280T1 (en) 2002-11-01 2011-03-01 ANTI-POLLUTION FACTORS

Country Status (2)

Country Link
CY (1) CY1111280T1 (en)
TW (1) TW200427678A (en)

Also Published As

Publication number Publication date
TW200427678A (en) 2004-12-16

Similar Documents

Publication Publication Date Title
CY1112108T1 (en) DISEASES OF USVITIS C
EP2361913A8 (en) Anti-infective agents
CY1109012T1 (en) NUCLEOSIDE DERIVATIVES AS RNA-dependent INFLAMMATORS OF RNA IMPLANT
CY1113038T1 (en) TRIETERCYCLIC UNITS, COMPOSITIONS, AND METHODS FOR CANCER TREATMENT
BR0305259A (en) Hcv ns5b polymerase inhibitors
EA200201279A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL HEPATITIS C
NO20070194L (en) Methods for the treatment of hepatitis C
CY1106207T1 (en) ANTIINIC NUCLEOSITE DERIVATIVES
NO20051969L (en) Nucleoside derivatives for the treatment of hepatitis C virus infection.
NO20045247L (en) Nucleoside derivatives for the treatment of hepatitis C virus infection
AR046202A1 (en) NUCLEOSIDIC COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS
MXPA05010338A (en) Pharmaceutical compositions for hepatitis c viral protease inhibitors.
EA200501689A1 (en) CONNECTIONS AS HEPATITIS C VIRUS INHIBITORS
EA200800932A1 (en) MODIFIED 4`-NUCLEOSIDE AS ANTI-VIRUS AGENTS
ATE413411T1 (en) SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS
BRPI0514591A (en) heterocyclic antiviral compounds
ATE542826T1 (en) HEPATITIS C VIRUS INHIBITORS
IS7533A (en) Hepatitis C virus inhibition
ATE466856T1 (en) COMPOUNDS AND METHODS FOR TREATING OR PREVENTING FLAVIVIRUS INFECTIONS
ATE498398T1 (en) CYCLOALKYL HETEROCYCLES FOR THE TREATMENT OF HEPATITIS C VIRUS
CY1111280T1 (en) ANTI-POLLUTION FACTORS
UA90477C2 (en) Methods for treating hepatitis c (variants)
ATE493408T1 (en) ANTINIFECTIVE AGENTS
EE9900188A (en) 1- (3-Aminoindazol-5-yl) -3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
UY26818A1 (en) VIRAL POLYMERASE INHIBITORS